Brain-targeted delivery of neuroprotective survival gene minimizing hematopoietic cell contamination: implications for Parkinson’s disease treatment
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Brain-targeted delivery of neuroprotective survival gene minimizing hematopoietic cell contamination: implications for Parkinson’s disease treatment ; volume:22 ; number:1 ; day:13 ; month:1 ; year:2024 ; pages:1-14 ; date:12.2024
Journal of translational medicine ; 22, Heft 1 (13.1.2024), 1-14, 12.2024
- Creator
-
Lee, Min Hak
Kang, Sukyeong
Um, Ki-Hwan
Lee, Seok Won
Hwang, Hyorin
Baek, Kyunghwa
Choi, Jin Woo
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12967-023-04816-x
- URN
-
urn:nbn:de:101:1-2024032609231568645888
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:55 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lee, Min Hak
- Kang, Sukyeong
- Um, Ki-Hwan
- Lee, Seok Won
- Hwang, Hyorin
- Baek, Kyunghwa
- Choi, Jin Woo
- SpringerLink (Online service)
Other Objects (12)
Interleukin-2 expands neuroprotective regulatory T cells in Parkinson’s disease
Neuroprotective effects of Shende’an tablet in the Parkinson’s disease model
Neuroprotective Effects of Dexamethasone in a Neuromelanin-Driven Parkinson’s Disease Model
Correction: Neuroprotective effects of Shende’an tablet in the Parkinson’s disease model
Safranal exerts a neuroprotective effect on Parkinson’s disease with suppression of NLRP3 inflammation activation
Sex-dimorphic neuroprotective effect of CD163 in an α-synuclein mouse model of Parkinson’s disease
Neuroprotective Effect of the Endogenous Amine 1MeTIQ in an Animal Model of Parkinson’s Disease
TMEM106B Knockdown Exhibits a Neuroprotective Effect in Parkinson’s Disease via Decreasing Inflammation and Iron Deposition
Gender biased neuroprotective effect of Transferrin Receptor 2 deletion in multiple models of Parkinson’s disease
Peripheral MC1R Activation Modulates Immune Responses and is Neuroprotective in a Mouse Model of Parkinson’s Disease
CtBP Neuroprotective Role in Toxin-Based Parkinson’s Disease Models: From Expression Pattern to Dopaminergic Survival
Repurposing Pomalidomide as a Neuroprotective Drug: Efficacy in an Alpha-Synuclein-Based Model of Parkinson’s Disease
Interleukin-2 expands neuroprotective regulatory T cells in Parkinson’s disease
Neuroprotective effects of Shende’an tablet in the Parkinson’s disease model
Neuroprotective Effects of Dexamethasone in a Neuromelanin-Driven Parkinson’s Disease Model
Correction: Neuroprotective effects of Shende’an tablet in the Parkinson’s disease model
Safranal exerts a neuroprotective effect on Parkinson’s disease with suppression of NLRP3 inflammation activation
Sex-dimorphic neuroprotective effect of CD163 in an α-synuclein mouse model of Parkinson’s disease
Neuroprotective Effect of the Endogenous Amine 1MeTIQ in an Animal Model of Parkinson’s Disease
TMEM106B Knockdown Exhibits a Neuroprotective Effect in Parkinson’s Disease via Decreasing Inflammation and Iron Deposition
Gender biased neuroprotective effect of Transferrin Receptor 2 deletion in multiple models of Parkinson’s disease
Peripheral MC1R Activation Modulates Immune Responses and is Neuroprotective in a Mouse Model of Parkinson’s Disease
CtBP Neuroprotective Role in Toxin-Based Parkinson’s Disease Models: From Expression Pattern to Dopaminergic Survival
Repurposing Pomalidomide as a Neuroprotective Drug: Efficacy in an Alpha-Synuclein-Based Model of Parkinson’s Disease
Interleukin-2 expands neuroprotective regulatory T cells in Parkinson’s disease
Neuroprotective effects of Shende’an tablet in the Parkinson’s disease model
Neuroprotective Effects of Dexamethasone in a Neuromelanin-Driven Parkinson’s Disease Model
Correction: Neuroprotective effects of Shende’an tablet in the Parkinson’s disease model
Safranal exerts a neuroprotective effect on Parkinson’s disease with suppression of NLRP3 inflammation activation
Sex-dimorphic neuroprotective effect of CD163 in an α-synuclein mouse model of Parkinson’s disease
Neuroprotective Effect of the Endogenous Amine 1MeTIQ in an Animal Model of Parkinson’s Disease
TMEM106B Knockdown Exhibits a Neuroprotective Effect in Parkinson’s Disease via Decreasing Inflammation and Iron Deposition
Gender biased neuroprotective effect of Transferrin Receptor 2 deletion in multiple models of Parkinson’s disease
Peripheral MC1R Activation Modulates Immune Responses and is Neuroprotective in a Mouse Model of Parkinson’s Disease
CtBP Neuroprotective Role in Toxin-Based Parkinson’s Disease Models: From Expression Pattern to Dopaminergic Survival